Chronic myelomonocytic leukemia: 2018 update on diagnosis, risk stratification and management
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chronic myelomonocytic leukemia: 2018 update on diagnosis, risk stratification and management
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF HEMATOLOGY
Volume 93, Issue 6, Pages 824-840
Publisher
Wiley
Online
2018-06-01
DOI
10.1002/ajh.25104
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cooperative Epigenetic Remodeling by TET2 Loss and NRAS Mutation Drives Myeloid Transformation and MEK Inhibitor Sensitivity
- (2018) Hiroyoshi Kunimoto et al. CANCER CELL
- FGFR1 rearranged hematological neoplasms – molecularly defined and clinically heterogeneous
- (2018) Mrinal M. Patnaik et al. LEUKEMIA & LYMPHOMA
- Infrequent occurrence of TET1, TET3, and ASXL2 mutations in myelodysplastic/myeloproliferative neoplasms
- (2018) Terra L. Lasho et al. Blood Cancer Journal
- EZH2 mutations in chronic myelomonocytic leukemia cluster with ASXL1 mutations and their co-occurrence is prognostically detrimental
- (2018) Mrinal M. Patnaik et al. Blood Cancer Journal
- Flow cytometry based monocyte subset analysis accurately distinguishes chronic myelomonocytic leukemia from myeloproliferative neoplasms with associated monocytosis
- (2017) M M Patnaik et al. Blood Cancer Journal
- Next generation sequencing of myeloid neoplasms with eosinophilia harboring theFIP1L1-PDGFRAmutation
- (2016) Animesh Pardanani et al. AMERICAN JOURNAL OF HEMATOLOGY
- Targeted next generation sequencing of PDGFRB rearranged myeloid neoplasms with monocytosis
- (2016) Mrinal M. Patnaik et al. AMERICAN JOURNAL OF HEMATOLOGY
- DNMT3A mutations are associated with inferior overall and leukemia-free survival in chronic myelomonocytic leukemia
- (2016) Mrinal M. Patnaik et al. AMERICAN JOURNAL OF HEMATOLOGY
- Treatment with Hypomethylating Agents before Allogeneic Stem Cell Transplant Improves Progression-Free Survival for Patients with Chronic Myelomonocytic Leukemia
- (2016) Piyanuch Kongtim et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia
- (2016) C. Elena et al. BLOOD
- When clinical heterogeneity exceeds genetic heterogeneity: thinking outside the genomic box in chronic myelomonocytic leukemia
- (2016) M. Ball et al. BLOOD
- The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
- (2016) D. A. Arber et al. BLOOD
- The Role of New Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia
- (2016) Priyanka A. Pophali et al. CANCER JOURNAL
- A Multi-Institution Phase I Trial of Ruxolitinib in Patients with Chronic Myelomonocytic Leukemia (CMML)
- (2016) E. Padron et al. CLINICAL CANCER RESEARCH
- Spectrum of autoimmune diseases and systemic inflammatory syndromes in patients with chronic myelomonocytic leukemia
- (2016) Mohammad Faizan Zahid et al. LEUKEMIA & LYMPHOMA
- Chronic Myelomonocytic Leukemia: Focus on Clinical Practice
- (2016) Mrinal M. Patnaik et al. MAYO CLINIC PROCEEDINGS
- Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents
- (2016) Jane Merlevede et al. Nature Communications
- Number and type of TET2 mutations in chronic myelomonocytic leukemia and their clinical relevance
- (2016) M M Patnaik et al. Blood Cancer Journal
- Cytogenetic and molecular abnormalities in chronic myelomonocytic leukemia
- (2016) M M Patnaik et al. Blood Cancer Journal
- Prognostic interaction between ASXL1 and TET2 mutations in chronic myelomonocytic leukemia
- (2016) M M Patnaik et al. Blood Cancer Journal
- Blast transformation in chronic myelomonocytic leukemia: Risk factors, genetic features, survival, and treatment outcome
- (2015) Mrinal M. Patnaik et al. AMERICAN JOURNAL OF HEMATOLOGY
- Characteristic repartition of monocyte subsets as a diagnostic signature of chronic myelomonocytic leukemia
- (2015) D. Selimoglu-Buet et al. BLOOD
- An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adults
- (2015) M. R. Savona et al. BLOOD
- Patients With Therapy-Related CMML Have Shorter Median Overall Survival Than Those With De Novo CMML: Mayo Clinic Long-Term Follow-Up Experience
- (2015) Salih Subari et al. Clinical Lymphoma Myeloma & Leukemia
- Cancer-associated ASXL1 mutations may act as gain-of-function mutations of the ASXL1–BAP1 complex
- (2015) Anand Balasubramani et al. Nature Communications
- ASXL1 mutated chronic myelomonocytic leukemia in a patient with familial thrombocytopenia secondary to germline mutation in ANKRD26
- (2015) J Perez Botero et al. Blood Cancer Journal
- Erratum: Chronic myelomonocytic leukemia in younger patients: molecular and cytogenetic predictors of survival and treatment outcome
- (2015) M M Patnaik et al. Blood Cancer Journal
- An international data set for CMML validates prognostic scoring systems and demonstrates a need for novel prognostication strategies
- (2015) E Padron et al. Blood Cancer Journal
- A Close Association of Autoimmune-Mediated Processes and Autoimmune Disorders with Chronic Myelomonocytic Leukemia: Observation from a Single Institution
- (2014) Deniz Peker et al. ACTA HAEMATOLOGICA
- Cytogenetic risk stratification of 417 patients with chronic myelomonocytic leukemia from a single institution
- (2014) Guilin Tang et al. AMERICAN JOURNAL OF HEMATOLOGY
- Molecular and prognostic correlates of cytogenetic abnormalities in chronic myelomonocytic leukemia: a Mayo Clinic-French Consortium Study
- (2014) Emnet A. Wassie et al. AMERICAN JOURNAL OF HEMATOLOGY
- TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients
- (2014) R. Bejar et al. BLOOD
- Chronic myelomonocytic leukaemia: a concise clinical and pathophysiological review
- (2014) Mrinal M. Patnaik et al. BRITISH JOURNAL OF HAEMATOLOGY
- ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients
- (2014) M M Patnaik et al. LEUKEMIA
- What is a promonocyte?
- (2013) Barbara J. Bain AMERICAN JOURNAL OF HEMATOLOGY
- Mutations in epigenetic modifiers in the pathogenesis and therapy of acute myeloid leukemia
- (2013) O. Abdel-Wahab et al. BLOOD
- GM-CSF-dependent pSTAT5 sensitivity is a feature with therapeutic potential in chronic myelomonocytic leukemia
- (2013) E. Padron et al. BLOOD
- Development and validation of a prognostic scoring system for patients with chronic myelomonocytic leukemia
- (2013) E. Such et al. BLOOD
- Clinical characteristics and outcomes of therapy-related chronic myelomonocytic leukemia
- (2013) K. Takahashi et al. BLOOD
- Clonal architecture of chronic myelomonocytic leukemias
- (2013) R. Itzykson et al. BLOOD
- Allogeneic stem cell transplantation for chronic myelomonocytic leukemia: a report from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire
- (2013) Sophie Park et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Role of Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem-Cell Transplantation in Older Patients With De Novo Myelodysplastic Syndromes: An International Collaborative Decision Analysis
- (2013) John Koreth et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia
- (2013) Raphaël Itzykson et al. JOURNAL OF CLINICAL ONCOLOGY
- An evolutionary perspective on chronic myelomonocytic leukemia
- (2013) R Itzykson et al. LEUKEMIA
- SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomonocytic leukemia and secondary acute myeloid leukemias
- (2013) F Damm et al. LEUKEMIA
- SETBP1 mutations in 415 patients with primary myelofibrosis or chronic myelomonocytic leukemia: independent prognostic impact in CMML
- (2013) R R Laborde et al. LEUKEMIA
- Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomes
- (2013) M M Patnaik et al. LEUKEMIA
- Predictive factors of response and survival among chronic myelomonocytic leukemia patients treated with azacitidine
- (2013) Lionel Adès et al. LEUKEMIA RESEARCH
- FLT3mutations in myelodysplastic syndrome and chronic myelomonocytic leukemia
- (2012) Naval Daver et al. AMERICAN JOURNAL OF HEMATOLOGY
- Spliceosome mutations involvingSRSF2,SF3B1, andU2AF35in chronic myelomonocytic leukemia: Prevalence, clinical correlates, and prognostic relevance
- (2012) Mrinal M. Patnaik et al. AMERICAN JOURNAL OF HEMATOLOGY
- Prognostic irrelevance of ring sideroblast percentage in World Health Organization-defined myelodysplastic syndromes without excess blasts
- (2012) M. M. Patnaik et al. BLOOD
- SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML)
- (2012) M. Meggendorfer et al. BLOOD
- ASXL1 Mutations Promote Myeloid Transformation through Loss of PRC2-Mediated Gene Repression
- (2012) Omar Abdel-Wahab et al. CANCER CELL
- Effects ofTET2mutations on DNA methylation in chronic myelomonocytic leukemia
- (2012) Jumpei Yamazaki et al. Epigenetics
- Impact of Azacitidine Before Allogeneic Stem-Cell Transplantation for Myelodysplastic Syndromes: A Study by the Société Française de Greffe de Moelle et de Thérapie-Cellulaire and the Groupe-Francophone des Myélodysplasies
- (2012) Gandhi Damaj et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment of chronic myelomonocytic leukemia with azacitidine
- (2012) Eric Wong et al. LEUKEMIA & LYMPHOMA
- High rate of remissions in chronic myelomonocytic leukemia treated with 5-azacytidine: results of an Italian retrospective study
- (2012) Luana Fianchi et al. LEUKEMIA & LYMPHOMA
- Treatment of chronic myelomonocytic leukemia with 5-Azacitidine: A case series and literature review
- (2012) Michael Thorpe et al. LEUKEMIA RESEARCH
- Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A
- (2011) A. M. Jankowska et al. BLOOD
- SF3B1 mutations are prevalent in myelodysplastic syndromes with ring sideroblasts but do not hold independent prognostic value
- (2011) M. M. Patnaik et al. BLOOD
- Molecular predictors of response to decitabine in advanced chronic myelomonocytic leukemia: a phase 2 trial
- (2011) T. Braun et al. BLOOD
- Phase I Study of Oral Azacitidine in Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, and Acute Myeloid Leukemia
- (2011) Guillermo Garcia-Manero et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular profiling of chronic myelomonocytic leukemia reveals diverse mutations in >80% of patients with TET2 and EZH2 being of high prognostic relevance
- (2011) V Grossmann et al. LEUKEMIA
- Concomitant analysis of EZH2 and ASXL1 mutations in myelofibrosis, chronic myelomonocytic leukemia and blast-phase myeloproliferative neoplasms
- (2011) O Abdel-Wahab et al. LEUKEMIA
- Cutaneous manifestations in CMML: Indication of disease acceleration or transformation to AML and review of the literature
- (2011) Rahel A. Mathew et al. LEUKEMIA RESEARCH
- Frequent pathway mutations of splicing machinery in myelodysplasia
- (2011) Kenichi Yoshida et al. NATURE
- Allogeneic Hematopoietic Cell Transplantation for Chronic Myelomonocytic Leukemia: Relapse-Free Survival Is Determined by Karyotype and Comorbidities
- (2010) Hesham Eissa et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Next-generation sequencing of the TET2 gene in 355 MDS and CMML patients reveals low-abundance mutant clones with early origins, but indicates no definite prognostic value
- (2010) A. E. Smith et al. BLOOD
- Nomenclature of monocytes and dendritic cells in blood
- (2010) L. Ziegler-Heitbrock et al. BLOOD
- Allogeneic haematopoietic SCT for chronic myelomonocytic leukaemia: a single-centre experience
- (2010) P Krishnamurthy et al. BONE MARROW TRANSPLANTATION
- ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia
- (2010) Véronique Gelsi-Boyer et al. BRITISH JOURNAL OF HAEMATOLOGY
- Activity of azacitidine in chronic myelomonocytic leukemia
- (2010) Rubens Costa et al. CANCER
- RAS Mutations Contribute to Evolution of Chronic Myelomonocytic Leukemia to the Proliferative Variant
- (2010) C. Ricci et al. CLINICAL CANCER RESEARCH
- Transcription factor mutations in myelodysplastic/myeloproliferative neoplasms
- (2010) T. Ernst et al. HAEMATOLOGICA
- Cytogenetic risk stratification in chronic myelomonocytic leukemia
- (2010) E. Such et al. HAEMATOLOGICA
- Next-Generation Sequencing Technology Reveals a Characteristic Pattern of Molecular Mutations in 72.8% of Chronic Myelomonocytic Leukemia by Detecting Frequent Alterations in TET2, CBL, RAS, and RUNX1
- (2010) Alexander Kohlmann et al. JOURNAL OF CLINICAL ONCOLOGY
- Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies
- (2009) O. Abdel-Wahab et al. BLOOD
- PD-1/PD-L1 interactions inhibit antitumor immune responses in a murine acute myeloid leukemia model
- (2009) L. Zhang et al. BLOOD
- Mutations of E3 Ubiquitin Ligase Cbl Family Members Constitute a Novel Common Pathogenic Lesion in Myeloid Malignancies
- (2009) Hideki Makishima et al. JOURNAL OF CLINICAL ONCOLOGY
- Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AML
- (2009) A Tefferi et al. LEUKEMIA
- RUNX1 mutations are frequent in chronic myelomonocytic leukemia and mutations at the C-terminal region might predict acute myeloid leukemia transformation
- (2009) M-C Kuo et al. LEUKEMIA
- Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs
- (2008) D. E. Rollison et al. BLOOD
- Genome profiling of chronic myelomonocytic leukemia: frequent alterations of RAS and RUNX1genes
- (2008) Véronique Gelsi-Boyer et al. BMC CANCER
- Outcome of allo-SCT for chronic myelomonocytic leukemia
- (2008) S Ocheni et al. BONE MARROW TRANSPLANTATION
- Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring System
- (2008) Hagop Kantarjian et al. CANCER
- On the use of lonafarnib in myelodysplastic syndrome and chronic myelomonocytic leukemia
- (2008) E J Feldman et al. LEUKEMIA
- Efficacy of decitabine in the treatment of patients with chronic myelomonocytic leukemia (CMML)
- (2007) P.W. Wijermans et al. LEUKEMIA RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now